Optigenex Inc. Stock Analysis OPGX

Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements, and personal care products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2005-04-15. The firm is focused on providing solutions for healthy age management. Its ac-11 is the patented compound that helps the body to repair its own deoxyribonucleic acid (DNA). Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The firm's technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation; maintains telomere length and integrity during the process of cellular mitosis, and increases production of natural collagen III.